Guozhi Zhang
Papers
1
Total Citations
50
H-Index
1
About
Dr. Guozhi Zhang is a leading surgical oncologist whose research centers on advancing breast cancer treatment through minimally invasive techniques. His most impactful work, the 2022 study "Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery," has garnered 50 citations and fundamentally addressed a critical gap in the literature. Prior to this study, the long-term prognostic data comparing minimal access breast surgery (MABS) to conventional breast surgery (CBS) were scarce, leaving clinicians uncertain about the oncologic safety of less invasive approaches. Dr. Zhang’s investigation provided robust evidence that MABS offers comparable long-term therapeutic outcomes to CBS, thereby validating its use in breast cancer management. This contribution has not only reassured surgeons and patients about the efficacy of MABS but has also helped shift clinical practice toward more patient-friendly, cosmetically superior options without compromising survival. By rigorously evaluating these outcomes, Dr. Zhang has established himself as a key figure in the evolution of breast cancer surgery, bridging the gap between innovation and evidence-based oncology.
Research Focus
Key Achievements
Top Papers
- 1